Clinical Trial Update: Effect of Sildenafil on the Microcirculatory Blood Flow and Endothelial Progenitor Cells in Systemic Sclerosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating sildenafil for improving microcirculatory blood flow and endothelial progenitor cell levels in systemic sclerosis has completed and pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Raynaud Phenomenon
• Systemic Sclerosis

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Federal University of São Paulo | Conditions: Scleroderma, Systemic, Scleroderma, Diffuse | Phase 3 | Status: COMPLETED | Results posted: 2016-12-05